Chronic effects assessment and plasma concentrations of the β-blocker propranolol in fathead minnows (Pimephales promelas)

Aquatic Toxicology

Volumn 95, Issue 3, 2009, Pages 195-202

  Giltrow, Emma ^a   Eccles, Paul D ^a   Winter, Matthew J ^b   McCormack, Paul J ^b   Rand Weaver, Mariann ^a   Hutchinson, Thomas H ^c   Sumpter, John P ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c PLYMOUTH MARINE LABORATORY   (United Kingdom)

Author keywords

Blocker; Fathead minnow; Fish plasma concentration; Pharmaceutical; Propranolol

Indexed keywords

PROPRANOLOL; WATER;

AQUATIC ENVIRONMENT; AQUATIC ORGANISM; DRUG; PLASMA; TOXICITY;

ARTICLE; CONCENTRATION PROCESS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXPOSURE; FEMALE; HATCHERY; MALE; MORTALITY; NONHUMAN; PIMEPHALES PROMELAS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEX DIFFERENCE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BODY SIZE; CYPRINIDAE; FEMALE; MALE; ORGAN SIZE; OVIPARITY; PROPRANOLOL; REPRODUCTION; SURVIVAL ANALYSIS; WATER; WATER POLLUTANTS, CHEMICAL; ZYGOTE;

MAMMALIA; PIMEPHALES PROMELAS;

EID: 71849105300     PISSN: 0166445X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquatox.2009.09.002     Document Type: Article

References (25)

1. Ankley G.T., Jensen K.M., Kahl M.D., Korte J.J., and Makynen E.A. Description and evaluation of a short-term reproduction test with the fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 20 (2001) 1276-1290
2. Ashton D., Hilton M., and Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 333 (2004) 167-184
3. Brown J.N., Paxeus N., Forlin L., and Larsson D.G.J. Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ. Toxicol. Pharmacol. 24 (2007) 267-274
4. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol. Lett. 142 (2003) 185-194
5. Cruickshank J.M., and Neil-Dwyer G. Beta-blocker brain concentrations in man. Eur. J. Clin. Pharmacol. 28 (1985) 21-23
6. Fent K., Weston A.A., and Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 76 (2006) 122-159
7. Harries J.E., Runnalls T., Hill E., Harris C.A., Maddix S., Sumpter J.P., and Tyler C.R. Development of a reproductive performance test for endocrine disrupting chemicals using pair-breeding fathead minnow (Pimephales promelas). Environ. Sci. Technol. 34 (2000) 3003-3011
8. Huggett D.B., Brooks B.W., Peterson B., Foran C.M., and Schlenk D. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (β-blockers) on aquatic organisms. Arch. Environ. Contam. Toxicol. 43 (2002) 229-235
9. Huggett D.B., Cook J.C., Ericson J.F., and Williams R.T. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum. Ecol. Risk Assess. 9 (2003) 1789-1799
10. Huggett D.B., Khan I.A., Foran C.M., and Schlenk D. Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent. Environ. Pollut. 121 (2003) 199-205
11. Jackson C.D., and Fishbein L. A toxicological review of beta-adrenergic blockers. Fund. Appl. Toxicol. 6 (1986) 395-422
12. Knacker T., Duis K., Ternes T., Fenner K., Escher B., Schmitt H., Rombke J., Garric J., Hutchinson T.H., and Boxall A.B. The EU-project ERAPharm, incentives for the further development of guidance documents?. Envrion. Sci. Pollut. Res. Int. 12 (2005) 62-65
13. Owen S.F., Giltrow E., Huggett D.B., Hutchinson T.H., Saye J., Winter M.J., and Sumpter J.P. Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish. Aquat. Toxicol. 82 (2007) 145-162
14. Owen S.F., Huggett D.B., Hutchinson T.H., Hetheridge M.J., Kinter L.B., Ericson J.F., and Sumpter J.P. Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry. Aquat. Toxicol. 93 (2009) 217-224
15. Purdom C.E., Hardiman P.A., Bye V.J., Eno N.C., Tyler C.R., and Sumpter J.P. Estrogenic effects of effluents from sewage treatment works. Chem. Ecol. 8 (1994) 75-285
16. Smith R.J.F. Seasonal changes in the histology of the gonads and dorsal skin of the fathead minnow, Pimephales promelas. Can. J. Zool. 56 (1978) 2103-2109
17. Srivastava M., and Kapoor N.K. The effect of propranolol on rat-brain catecholamine biosynthesis. J. Biosci. 5 (1983) 261-266
18. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32 (1998) 3245-3260
19. Ternes T., Bonerz M., and Schmidt T. Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 938 (2001) 175-185
20. Thorpe K.L., Benstead R., Hutchinson T.H., and Tyler C.R. An optimised experimental test procedure for measuring chemical effects on reproduction in the fathead minnow, Pimephales promelas. Aquat. Toxicol. 81 (2007) 90-98
21. Villegas-Navarro A., Rosas-L E., and Reyes J.L. The heart of Daphnia magna: effects of four cardioactive drugs. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 136 (2003) 127-134
22. Vu, J., Beckwith, M.C., 2007. Central nervous system side effects of beta-adrenergic blocking agents. http://health.utah.gov/medicaid/pharmacy.
23. Westerlund A. Central nervous-system side-effects with hydrophilic and lipophilic beta-blockers. Eur. J. Clin. Pharmacol. 28 (1985) 73-76
24. Winter M.J., Lillicrap A.D., Caunter J.E., Schaffner C., Alder A.C., Ramil M., Ternes T.A., Giltrow E., Sumpter J.P., and Hutchinson T.H. Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas). Aquat. Toxicol. 86 (2008) 361-369
25. Wong L., Nation R.L., Chiou W.L., and Mehta P.K. Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy. Br. J. Clin. Pharmacol. 8 (1979) 163-167